
MyRa helps cancer doctors tailor radiotherapy by predicting how a tumor will respond. The system combines a clinically validated biomarker with proprietary AI to forecast external beam radiation therapy outcomes. It targets B2B oncology workflows for clinics and cancer centers. Key technologies include the biomarker platform and AI analytics that integrate with clinical data to provide actionable guidance. The solution aims to improve treatment personalization and outcomes at scale across healthcare providers.

MyRa helps cancer doctors tailor radiotherapy by predicting how a tumor will respond. The system combines a clinically validated biomarker with proprietary AI to forecast external beam radiation therapy outcomes. It targets B2B oncology workflows for clinics and cancer centers. Key technologies include the biomarker platform and AI analytics that integrate with clinical data to provide actionable guidance. The solution aims to improve treatment personalization and outcomes at scale across healthcare providers.